Timing of revenue recognition
Schrodinger·Products & Services·3 segments
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Drug discovery | 8.7% | 19.3% | 9.7% | — | 15.1% | 20.5% | 24.8% | 39.1% |
| Software products and services | 48.7% | 40.1% | 50% | 8.4% | 43% | 44.6% | 41.8% | 36.5% |
| Contribution | — | — | — | — | — | — | — | 0.2% |
| Total | 48.7% | 40.1% | 50% | 8.4% | 43% | 44.6% | 41.8% | 36.5% |